Thomas Vo - 28 Jun 2024 Form 4 Insider Report for Nutex Health, Inc. (NUTX)

Role
Chief Executive Officer, Director
Signature
/s/ Thomas T. Vo
Issuer symbol
NUTX
Transactions as of
28 Jun 2024
Net transactions value
$0
Form type
4
Filing time
28 Jun 2024, 11:37:48 UTC
Previous filing
30 May 2024
Next filing
15 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUTX Restricted Stock Unit Award $0 +150,000 $0.000000 150,000 28 Jun 2024 Common Stock 150,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.
F2 Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Dr. Vo, dated June 28, 2024, the 150,000 RSUs granted to Dr. Vo will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.